Matches in Nanopublications for { ?s ?p "[RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP605321.RAayyGMwIkMNa7PH6emhjSza61M6cVx2ZDWUc2NT7gUgc130_assertion description "[RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605321.RAayyGMwIkMNa7PH6emhjSza61M6cVx2ZDWUc2NT7gUgc130_provenance.
- NP717226.RAWTsk01YU73x4HYuKkz-joM7xbNxzcQTKYnW900eNRDU130_assertion description "[RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717226.RAWTsk01YU73x4HYuKkz-joM7xbNxzcQTKYnW900eNRDU130_provenance.
- assertion description "[RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1116741.RAb-vjrKFluEpCfBe0vicpWBc9le8MH6tIGXa1xiTrZ9Q130_assertion description "[RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116741.RAb-vjrKFluEpCfBe0vicpWBc9le8MH6tIGXa1xiTrZ9Q130_provenance.
- NP605428.RAnbPjgG_6Kcdfgaf0qlqzOGfWD99-ytDWyuIqOeH3LYs130_assertion description "[RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605428.RAnbPjgG_6Kcdfgaf0qlqzOGfWD99-ytDWyuIqOeH3LYs130_provenance.
- NP1116733.RAo6LL5PxgUfF3wmVO2E0hcFBLEfvbae6bRd4UZlm_0ro130_assertion description "[RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116733.RAo6LL5PxgUfF3wmVO2E0hcFBLEfvbae6bRd4UZlm_0ro130_provenance.
- NP1116739.RAtrYVI850_B9WH_Y-G5LmHfFltQReOF1UYRed9troso8130_assertion description "[RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116739.RAtrYVI850_B9WH_Y-G5LmHfFltQReOF1UYRed9troso8130_provenance.
- NP1116738.RAIIYiNEBzE3N6ukN7arh0UhSWVYdHOIw49H0p6uIL03g130_assertion description "[RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116738.RAIIYiNEBzE3N6ukN7arh0UhSWVYdHOIw49H0p6uIL03g130_provenance.
- NP716740.RA1Mr5gXggh2vTDwT83QlczHopm_MaQ_TCsXqrx6PBmxE130_assertion description "[RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP716740.RA1Mr5gXggh2vTDwT83QlczHopm_MaQ_TCsXqrx6PBmxE130_provenance.